Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

Article English OPEN

Mélanie Saint-Jean; Anne-Chantal Knol; Christelle Volteau; Gaëlle Quéreux; Lucie Peuvrel; Anabelle Brocard; Marie-Christine Pandolfino; Soraya Saiagh; Jean-Michel Nguyen; Christophe Bedane; Nicole Basset-Seguin; Amir Khammari; Brigitte Dréno;

(2018)

Publisher: Hindawi Limited

Journal: Journal of Immunology Research (issn: 2314-8861, eissn: 2314-7156)

Publisher copyright policies & self-archiving

Related identifiers: doi: 10.1155/2018/3530148
Subject: RC581-607 | Immunologic diseases. Allergy
mesheuropmc: chemical and pharmacologic phenomena | hemic and immune systems

Immunotherapy for melanoma includes adoptive cell therapy with autologous tumor-infiltrating lymphocytes (TILs). This monocenter retrospective study was undertaken to evaluate the efficacy and safety of this treatment of patients with advanced melanoma. All advanced mel... View more

Metrics

Share - Bookmark

Download from
Journal of Immunology Research via DOAJ-Articles (Article, 2018)
Hindawi Limited/ Journal of Immunology Research
Cite this publication